Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women – PREFER a Randomized, Placebo-Controlled Study
出版年份 2014 全文链接
标题
Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women – PREFER a Randomized, Placebo-Controlled Study
作者
关键词
Fatigue, Ferritin, Tea, Hemoglobin, Adverse events, Headaches, Reticulocytes, Iron deficiency
出版物
PLoS One
Volume 9, Issue 4, Pages e94217
出版商
Public Library of Science (PLoS)
发表日期
2014-04-22
DOI
10.1371/journal.pone.0094217
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Measuring the Global Burden of Disease
- (2013) Christopher J.L. Murray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cognitive Factors Mediate Placebo Responses in Patients with House Dust Mite Allergy
- (2013) Sabine Vits et al. PLoS One
- Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron
- (2012) M. Aapro et al. ANNALS OF ONCOLOGY
- UK guidelines on the management of iron deficiency in pregnancy
- (2012) Sue Pavord et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial
- (2012) P. Vaucher et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Ferric carboxymaltose for the treatment of iron-deficiency anemia
- (2012) Manuel Muñoz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Comparisons of Exercise Dose and Symptom Severity Between Exercisers and Nonexercisers in Women During and After Cancer Treatment
- (2012) Maria H. Cho et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Ironing out fatigue
- (2011) A. von Drygalski et al. BLOOD
- Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration
- (2011) P.-A. Krayenbuehl et al. BLOOD
- FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease
- (2011) Rayko Evstatiev et al. GASTROENTEROLOGY
- Iron sensing and signalling
- (2011) Rayko Evstatiev et al. GUT
- Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients with Cancer- or Chemotherapy-Induced Anemia
- (2011) T.D. Szucs et al. ONCOLOGY
- Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum
- (2010) Christian Breymann et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
- (2010) Robert Buynak et al. EXPERT OPINION ON PHARMACOTHERAPY
- A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
- (2010) Wajeh Y. Qunibi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Psychological treatment of depression in primary care: a meta-analysis
- (2009) Pim Cuijpers et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
- (2009) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- BLOOD MANAGEMENT: Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial
- (2009) David B. Van Wyck et al. TRANSFUSION
- A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial
- (2008) Stefanie Kulnigg et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia
- (2008) Christian Breymann et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More